Clinical Trial Update: Hyper-CVAD Treatment in Lymphoblastic Lymphoma

View source ↗

Summary

This entry describes a clinical trial evaluating the Hyper-CVAD regimen for lymphoblastic lymphoma, with the study status currently listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoblastic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• Vincristine (vincristine)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Lymphoblastic Lymphoma | Status: UNKNOWN